Q: What is the clinical evidence from this study?

Study design: Cohort. Population: End-stage renal disease on continuous ambulatory peritoneal dialysis (n=53). Intervention: Mitral valve or anular sclerosis or calcification (MC) vs. Patients without MC. Primary outcome: Survival.

Question 1

What are the key findings of this study?

Accepted Answer

Severe mitral valve calcification and grade III mitral valve regurgitation were more frequent in nonsurvivors than in survivors among CAPD patients (p < 0.03).

Question 2

What is the clinical evidence from this study?

Accepted Answer

Study design: Cohort. Population: End-stage renal disease on continuous ambulatory peritoneal dialysis (n=53). Intervention: Mitral valve or anular sclerosis or calcification (MC) vs. Patients without MC. Primary outcome: Survival.

Question 3

What does this research mean for the field?

Accepted Answer

Severe mitral valve calcification and grade III mitral valve regurgitation are significantly more frequent in nonsurvivors than in survivors among end-stage renal disease patients on continuous ambulatory peritoneal dialysis. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

Predictive Value of Mitral and Aortic Valve Sclerosis for Survival in End-Stage Renal Disease on Continuous Ambulatory Peritoneal Dialysis

Discussion

Member takes

Overview

Study Design

PICO

Cite This Study